Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03983681 · ClinicalTrials.gov registry record · NA

Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Active
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT03983681 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by Kessler Foundation. The registered enrollment target is 120 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03983681, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Kessler Foundation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.

Conditions Studied

Interventions

  • BEHAVIORAL Strategy-Based Training to Enhance Memory (STEM)
  • BEHAVIORAL Placebo control exercises

Study Locations (2)

New Jersey

  • Kessler Foundation - East Hanover
  • Kessler Rehabilitation Center - Marlton

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2019-09-26
Est. Completion 2025-09-30
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT03983681

The ClinicalTrials.gov registry entry for NCT03983681 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (79% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Strategy-Based Training to Enhance Memory (STEM) is the first listed.

NCT03983681 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03983681 about?

NCT03983681 is a clinical study titled "Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS". The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.

What is the current status of trial NCT03983681?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2019-09-26. Estimated completion is 2025-09-30.

What conditions does trial NCT03983681 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03983681?

The interventions under investigation include: Strategy-Based Training to Enhance Memory (STEM) (BEHAVIORAL), Placebo control exercises (BEHAVIORAL).

Who is sponsoring clinical trial NCT03983681?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03983681 being conducted?

This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.